Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Medicine|January 9, 2020
Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel diseaseSaara Huoponen, Anja Eberl, Pirjo Räsänen, et al.Digestive Diseases and Sciences|February 13, 2025
Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel DiseaseJaakko Rautakorpi, Sara Kolehmainen, Eliisa Löyttyniemi, et al.European Journal of Gastroenterology & Hepatology|July 8, 2024
Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel diseaseSara Kolehmainen, Jaakko Rautakorpi, Eliisa Löyttyniemi, et al.Inflammatory Bowel Diseases|September 23, 2010
Endoscopic monitoring of infliximab therapy in Crohn's diseaseClas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen, et al.Inflammatory Bowel Diseases|June 12, 2014
Skin reactions during anti-TNFα therapy for pediatric inflammatory bowel disease: a 2-year prospective studyTarja Mälkönen, Anne Wikström, Kaarina Heiskanen, et al.Scandinavian Journal of Gastroenterology|December 26, 2009
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatmentTaina Sipponen, Clas-Göran A F Björkesten, Martti Färkkilä, et al.Pediatric Surgery International|August 12, 2009
Sexual functions in adulthood after restorative proctocolectomy for paediatric onset ulcerative colitisAntti Koivusalo, Mikko P Pakarinen, Johanna Natunen, et al.Scandinavian Journal of Gastroenterology|May 28, 2011
Capsule endoscopy in pediatric patients: technique and results in our first 100 consecutive childrenHannu Nuutinen, Kaija-Leena Kolho, Päivi Salminen, et al.Scandinavian Journal of Gastroenterology|November 26, 2014
Surgical rehabilitation of short and dysmotile intestine in children and adultsMaria Hukkinen, Laura Merras-Salmio, Taina Sipponen, et al.Scandinavian Journal of Gastroenterology|March 3, 2022
Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre studyHeli Eronen, Sara Kolehmainen, Jukka Koffert, et al.Pageof 7